当前位置:首页 - 行情中心 - 海尔生物(688139) - 财务分析 - 现金流量表

海尔生物

(688139)

  

流通市值:104.28亿  总市值:104.28亿
流通股本:3.16亿   总股本:3.16亿

现金流量表

报告期2025-12-312025-09-302025-06-302025-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,444,397,545.971,681,571,829.291,156,363,413.19553,238,068.82
  收到的税费返还38,320,562.7628,202,468.0324,623,824.358,890,451.89
  收到其他与经营活动有关的现金54,358,007.7949,860,321.2918,378,285.0718,575,983.36
  经营活动现金流入小计2,537,076,116.521,759,634,618.611,199,365,522.61580,704,504.07
  购买商品、接受劳务支付的现金1,193,137,579.66880,864,392.6650,033,142.42265,382,591.23
  支付给职工以及为职工支付的现金647,242,346.78481,731,863.06333,363,699.84182,109,920.34
  支付的各项税费138,101,835.69101,364,948.8571,377,311.1535,877,317.22
  支付其他与经营活动有关的现金290,699,981.21213,030,277.78108,951,302.4460,115,473.74
  经营活动现金流出小计2,269,181,743.341,676,991,482.291,163,725,455.85543,485,302.53
  经营活动产生的现金流量净额267,894,373.1882,643,136.3235,640,066.7637,219,201.54
二、投资活动产生的现金流量:
  收回投资收到的现金3,955,764,141.173,139,860,0002,279,900,0001,102,900,000
  取得投资收益收到的现金22,067,445.8917,124,148.9113,120,658.216,637,955.23
  处置固定资产、无形资产和其他长期资产收回的现金净额455,473.89358,28090,338.23-
  投资活动现金流入小计3,978,287,060.953,157,342,428.912,293,110,996.441,109,537,955.23
  购建固定资产、无形资产和其他长期资产支付的现金119,254,456.2480,869,727.0968,398,152.1228,103,424.73
  投资支付的现金3,785,640,0002,944,800,0002,175,569,771.63954,000,000
  取得子公司及其他营业单位支付的现金56,647,50056,647,50047,647,50045,000,000
  投资活动现金流出小计3,961,541,956.243,082,317,227.092,291,615,423.751,027,103,424.73
  投资活动产生的现金流量净额16,745,104.7175,025,201.821,495,572.6982,434,530.5
三、筹资活动产生的现金流量:
  吸收投资收到的现金225,000---
  其中:子公司吸收少数股东投资收到的现金225,000---
  取得借款收到的现金20,000,00020,000,00020,000,00015,000,000
  收到其他与筹资活动有关的现金717,966,461.12538,303,291.65358,868,861.1179,362,611.12
  筹资活动现金流入小计738,191,461.12558,303,291.65378,868,861.1194,362,611.12
  偿还债务支付的现金10,010,00010,000,00010,000,0005,000,000
  分配股利、利润或偿付利息支付的现金150,295,702.61148,510,068.41148,454,174.72136,486.11
  其中:子公司支付给少数股东的股利、利润2,938,276.5---
  支付其他与筹资活动有关的现金846,622,175.04645,325,067.21435,948,901.54207,394,777.29
  筹资活动现金流出小计1,006,927,877.65803,835,135.62594,403,076.26212,531,263.4
  筹资活动产生的现金流量净额-268,736,416.53-245,531,843.97-215,534,215.16-18,168,652.28
四、汇率变动对现金及现金等价物的影响3,199,531.71,655,825.715,555,997.041,204,511.81
五、现金及现金等价物净增加额19,102,593.06-86,207,680.12-172,842,578.67102,689,591.57
  加:期初现金及现金等价物余额534,704,030.68534,704,030.68534,704,030.68534,704,030.68
  期末现金及现金等价物余额553,806,623.74448,496,350.56361,861,452.01637,393,622.25
补充资料:
  净利润255,132,280.57-147,213,041.4-
  资产减值准备8,507,764.46-2,932,521.61-
  固定资产和投资性房地产折旧71,800,978.78-35,622,434.12-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧71,032,333.78-35,238,111.62-
    投资性房地产折旧768,645-384,322.5-
  无形资产摊销48,373,937.95-24,164,032.34-
  长期待摊费用摊销2,328,495.2-1,145,098.75-
  递延收益摊销-3,263,645.16--1,631,822.66-
  处置固定资产、无形资产和其他长期资产的损失-632,148.71-18,792.77-
  固定资产报废损失1,225,721.96-171,159.07-
  公允价值变动损失494,110.38--1,894,977.61-
  财务费用-21,561,678.65--13,611,814.62-
  投资损失-27,308,983.33--15,907,644.87-
  递延所得税-31,895,649.67--13,314,357.87-
  其中:递延所得税资产减少-23,666,047.65--10,199,357.76-
    递延所得税负债增加-8,229,602.02--3,115,000.11-
  存货的减少-18,645,073.77-29,355,937.96-
  经营性应收项目的减少-68,683,543.49--95,632,254.5-
  经营性应付项目的增加34,073,537.69--79,564,536.38-
  现金的期末余额553,806,623.74-361,861,452.01-
  减:现金的期初余额534,704,030.68-534,704,030.68-
  现金及现金等价物的净增加额19,102,593.06--172,842,578.67-
公告日期2026-03-282025-10-312025-08-272025-04-30
审计意见(境内)标准无保留意见
TOP↑